Parkinson's Is a Man-Made Disease: The Chemicals Linked to a 500% Higher Risk | Dr. Ray Dorsey

For most individuals, the pathology of Parkinson's and Alzheimer's disease begins in the nose with misfolded protein and spreads backwards into the brain.

"And the pathology, for most individuals the pathology of both these diseases begins in the nose with misfolded protein and then spreads backwards to the parts of the brain that control motor function in Parkinson's, and backwards to the part of the brain that controls memory in Alzheimer's disease." (said at 0:32:02)

The speaker states as an established fact that for 'most individuals' pathology begins in the nose with misfolded protein and spreads into the brain for both Parkinson's and Alzheimer's disease. While early olfactory involvement and smell deficits are well documented in both disorders, an initial nasal origin is a theoretical model (the olfactory vector hypothesis / Braak dual-hit hypothesis) rather than a confirmed universal pathway. In Parkinson's disease, Lewy pathology is hypothesized to originate either in the enteric nervous system (gut-first) or the olfactory bulb/dorsal motor nucleus (brain-first). In Alzheimer's disease, classical neuropathological staging (Braak and Thal staging) typically identifies the earliest hyperphosphorylated tau lesions in the locus coeruleus/transentorhinal cortex and amyloid-beta in neocortical regions, not the nasal mucosa. Presenting nasal initiation as the established mechanism for most cases of both diseases is therefore an overstatement.

• context: The olfactory vector hypothesis of neurodegenerative disease: is it viable? (Annals of neurology 2008) · cited 403x in the literature

  "The presence of smell loss and the pathological involvement of the olfactory pathways in the formative stages of Alzheimer's and Parkinson's diseases, together with evidence that xenobiotics, some epidemiologically linked to these diseases, can readily enter the brain via the olfactory mucosa, have led to the hypothesis that Alzheimer's and Parkinson's diseases may be caused or catalyzed by agents that enter the brain via this route." (abstract, review, passage verified)

  pubmedfull study (doi)
• context: Olfactory bulb involvement in neurodegenerative diseases. (Acta neuropathologica 2014) · cited 361x in the literature

  "Olfactory dysfunction is a common and early symptom of many neurodegenerative diseases, particularly of Parkinson's disease and other synucleinopathies, Alzheimer's disease (AD), and mild cognitive impairment heralding its progression to dementia." (abstract, results, passage verified)

  pubmedfull study (doi)
• partial: Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors. (Nature reviews. Neurology 2015) · cited 610x in the literature

  "The neuropathological process that leads to PD seems to start in the ENS or the olfactory bulb and spreads via rostrocranial transmission to the substantia nigra and further into the CNS, raising the intriguing possibility that environmental substances can trigger pathogenesis." (abstract, results/conclusions, passage verified)

  pubmedfull study (doi)

The Lancet report identified 14 modifiable risk factors for dementia.

"Yeah, you know that Lancet report was actually quite interesting because they identified 14 modifiable factors and most of them dealt with our metabolism." (said at 1:03:45)

The speaker's statement bundles two claims: 1. The Lancet report identified 14 modifiable risk factors for dementia: This is SUPPORTED. The 2024 Lancet Commission report on dementia prevention, intervention, and care updated its model to 14 modifiable risk factors (adding high LDL cholesterol and untreated vision loss to the 12 factors from the 2020 report). 2. Most of them dealt with metabolism: This is CONTRADICTED. Only a minority of the 14 factors are primary metabolic/cardiometabolic markers (e.g., diabetes, obesity, high LDL cholesterol, hypertension). The majority comprise sensory, cognitive, behavioral, and environmental factors, including lower early-life education, hearing loss, vision loss, traumatic brain injury, depression, social isolation, smoking, excessive alcohol consumption, physical inactivity, and air pollution. Following the rubric to score bundled assertions by their least accurate part, the overall verdict is overstated/contradicted.

• partial: The potential for dementia prevention in Brazil: a population attributable fraction calcul… (Lancet regional health. Americas 2025) · cited 10x in the literature

  "The Lancet Commission on dementia prevention, intervention, and care 2024 updated the list of modifiable risk factors to include 14 factors." (abstract, passage verified)

  pubmedfull study (doi)
• partial: Broadening dementia risk models: building on the 2024 Lancet Commission report for a more … (EBioMedicine 2025) · cited 31x in the literature

  "The 2024 Lancet Commission Report on dementia prevention has identified 14 modifiable risk factors that account for approximately 45% of global dementia cases." (abstract, passage verified)

  pubmedfull study (doi)
• partial: The potential for dementia prevention in Japan: a population attributable fraction calcula… (The Lancet regional health. Western Pacific 2026) · cited 5x in the literature

  "Hearing loss (6.7%), physical inactivity (6.0%), and high LDL cholesterol (4.5%) were the largest contributors." (abstract, results, passage verified)

  pubmedfull study (doi)